Silvercrest Asset Management’s Exact Sciences EXAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
9,838
+300
| +3% | +$15.9K | ﹤0.01% | 708 |
|
|
2025
Q1 | $413K | Buy |
9,538
+1,546
| +19% | +$66.9K | ﹤0.01% | 734 |
|
|
2024
Q4 | $449K | Buy |
7,992
+641
| +9% | +$36K | ﹤0.01% | 709 |
|
|
2024
Q3 | $501K | Sell |
7,351
-2,451
| -25% | -$167K | ﹤0.01% | 650 |
|
|
2024
Q2 | $414K | Buy |
9,802
+3,275
| +50% | +$138K | ﹤0.01% | 752 |
|
|
2024
Q1 | $451K | Buy |
6,527
+72
| +1% | +$4.97K | ﹤0.01% | 725 |
|
|
2023
Q4 | $478K | Sell |
6,455
-114
| -2% | -$8.43K | ﹤0.01% | 675 |
|
|
2023
Q3 | $448K | Buy |
6,569
+212
| +3% | +$14.5K | ﹤0.01% | 691 |
|
|
2023
Q2 | $597K | Buy |
6,357
+1,875
| +42% | +$176K | ﹤0.01% | 659 |
|
|
2023
Q1 | $304K | Buy |
+4,482
| New | +$304K | ﹤0.01% | 718 |
|
|
2022
Q2 | – | Sell |
-4,250
| Closed | -$297K | – | 823 |
|
|
2022
Q1 | $297K | Buy |
4,250
+231
| +6% | +$16.1K | ﹤0.01% | 764 |
|
|
2021
Q4 | $313K | Buy |
4,019
+228
| +6% | +$17.8K | ﹤0.01% | 734 |
|
|
2021
Q3 | $362K | Sell |
3,791
-97
| -2% | -$9.26K | ﹤0.01% | 728 |
|
|
2021
Q2 | $483K | Sell |
3,888
-439
| -10% | -$54.5K | ﹤0.01% | 678 |
|
|
2021
Q1 | $570K | Buy |
4,327
+458
| +12% | +$60.3K | ﹤0.01% | 641 |
|
|
2020
Q4 | $513K | Buy |
3,869
+843
| +28% | +$112K | ﹤0.01% | 628 |
|
|
2020
Q3 | $309K | Buy |
+3,026
| New | +$309K | ﹤0.01% | 670 |
|